Cue Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 547 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 376-400 of 547 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
06 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Dec 2019
Reporting date
27 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Dec 2019
Reporting date
23 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2019
Reporting date
17 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90232

SC 13D filing

Filing date
18 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
26 Nov 2019
Reporting date
22 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-229140

424B5

Filing date
25 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
12 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Nov 2019
Reporting date
01 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
09 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
07 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

FORM 8-K

Filing date
07 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

FORM 8-K

Filing date
06 Aug 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
31 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .